3 in 1 (cTnI/CK-MB/Myo) Rapid Quantitative Test

Sales

3 in 1 test kit has a very high specificity and sensitivity for the detection of AMI, making a correct and timely diagnosis for patients with chest pain or clinically suspected AMI, and thus providing validly basis for clinicians with prompt rescue and treatment.

Product Detail

Product Introduction

The creatine troponin complex, formed by cardiac muscle creatine troponin I (cTnI), troponin T (TnT), and troponin C (TnC), can adjust the interaction between actin and myosin. The concentration of cTnI is rare low in healthy human blood; However, when acute myocardium infarction occurs, the cTnI is released into the blood quickly and the concentration of cTnI increases from the fourth hour to the sixth hours, which can maintain 6 days to 10 days. Therefore, cTnI is regarded as a marker for myocardial infarction.

Creatine Kinase(CK) is a dimer existing as three isoenzymes. CK mainly exists in skeletal muscle, cardiac muscle, and brain tissue. There are three types of isoenzymes, including BB (brain type), MM (skeleton-type), and MB(hybridization type). The level of CK- MB in the blood is abnormal after the fourth hour to the sixth hour with the symptom of acute myocardial infarction; furthermore, it reaches its peak at the 18th-24th hour and recovers to its normal level after the second or the third day. Thus CK-MB is regarded as a marker for acute myocardial infarction.

Myo is a plasmon of low molecular weight, whose speed released is faster than another label of the heart muscle when the heart is hurt. Its concentration exceeds the normal level after 1 hour and reaches a peak after the fourth or the eighth hour when faced with myocardial infarction. Therefore, Myo is regarded as a marker for early acute myocardial infarction.

Product Specification

Specimen Types	WB/Plasma
Specimen Capacity	WB:80μL; Plasma:50μL
Reaction Time	15 min
Sample Capacity	80μL
Clinical Significance	cTnI>0.3ng/mL; Myo>55ng/mL; CK-MB>5ng/mL High risk of MI

Advantages

√ Equipped with special dropper consumables, the operation is easier and more suitable for clinical use
√ Low sample requirements: whole blood can be processed without centrifugation
√ 3 in 1 (cTnI/CK-MB/Myo) detections improve the sensitivity and accuracy of results and reduce misdiagnosis caused by window reasons

Clinical significance
√ 3 in 1 (cTnI/CK-MB/Myo) detection has high sensitivity, better specificity, and more accurate results
√ Assess the area of myocardial infarction, detect reperfusion and recurrence of myocardial infarction, etc.
√ As an important indicator of brain injury, nervous system disease, carbon monoxide poisoning diagnosis, and treatment effect evaluation

Application
ICU, Respiratory Medicine, Emergency Department, Cardiology, Laboratory, Emergency Car

Tags : cardiac combo test cardiac biomarker test AMI test

Leave A Message

If you are interested in our products and want to know more details,please leave a message here,we will reply you as soon as we can.

Subject : 3 in 1 (cTnI/CK-MB/Myo) Rapid Quantitative Test

SUPPLIER

Xiamen Biotime Biotechnology Co., Ltd.

Gold Supplier

Visit Store

Sales

Product Detail

previous pots

next pots

Let's keep in touch!

3 in 1 (cTnI/CK-MB/Myo) Rapid Quantitative Test

Sales 3 in 1 (cTnI/CK-MB/Myo) Rapid Quantitative Test

Product Detail

previous pots

next pots

Let's keep in touch!

Sales